Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
ADVL1412, A Phase 1/2 Study of Nivolumab in Children Adolescents, and Young Adults with Recurrent or Refractory Solid Tumors as a Single Agent and in Combination with Ipilimumab
Grant
Overview
Affiliation
Overview
Date/time Interval
June 1, 2015 - May 31, 2018
Awarded By
CHILDREN'S HOSPITAL (PHILADELPHIA)
Total Award Amount
23222.00
Direct Costs
18431.00
Sponsor Award Id
Affiliation
Contributor
Ana Galtarossa Xavier
Investigator
Wayne Liang
Investigator